Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes

ClinicalTrials.gov ID: NCT00214630

Public ClinicalTrials.gov record NCT00214630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 15, 2026, 6:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-week Randomized, Open-label 3-arm, Parallel Group, Multicenter Phase IIIb Study Comparing Efficacy and Safety of Rosuvastatin 20mg and 40mg With That of Atorvastatin 80 mg in Subjects With Acute Coronary Syndromes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes

Study identification

NCT ID
NCT00214630
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
825 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2003
Primary completion
Jul 31, 2007
Completion
Jul 31, 2007
Last update posted
Nov 18, 2010

2003 – 2007

United States locations

U.S. sites
52
U.S. states
27
U.S. cities
52
Facility City State ZIP Site status
Research Site San Diego California
Research Site Torrance California
Research Site Bridgeport Connecticut
Research Site Atlantis Florida
Research Site Brandon Florida
Research Site Jacksonville Florida
Research Site Pensacola Florida
Research Site Safety Harbor Florida
Research Site Tampa Florida
Research Site Aurora Illinois
Research Site Chicago Illinois
Research Site Lombard Illinois
Research Site Melrose Park Illinois
Research Site Peoria Illinois
Research Site Anderson Indiana
Research Site Indianapolis Indiana
Research Site Des Moines Iowa
Research Site Louisville Kentucky
Research Site Owensboro Kentucky
Research Site Covington Louisiana
Research Site Shreveport Louisiana
Research Site Annapolis Maryland
Research Site Towson Maryland
Research Site Ann Arbor Michigan
Research Site Pontiac Michigan
Research Site Troy Michigan
Research Site Minneapolis Minnesota
Research Site Saint Paul Minnesota
Research Site Tupelo Mississippi
Research Site Kansas City Missouri
Research Site St Louis Missouri
Research Site Kalispell Montana
Research Site Newark New Jersey
Research Site Albuquerque New Mexico
Research Site Rochester New York
Research Site Asheville North Carolina
Research Site Cincinnati Ohio
Research Site Fairview Park Ohio
Research Site Springfield Ohio
Research Site Oklahoma City Oklahoma
Research Site Tulsa Oklahoma
Research Site Bend Oregon
Research Site Portland Oregon
Research Site Danville Pennsylvania
Research Site Memphis Tennessee
Research Site Amarillo Texas
Research Site Beaumont Texas
Research Site Dallas Texas
Research Site Lubbock Texas
Research Site Chesapeake Virginia
Research Site Burien Washington
Research Site Wausau Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00214630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2010 · Synced Sep 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00214630 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →